Table of Contents Author Guidelines Submit a Manuscript
Schizophrenia Research and Treatment
Volume 2012 (2012), Article ID 560836, 8 pages
Review Article

Long-Acting Injectable Antipsychotics for First-Episode Schizophrenia: The Pros and Cons

1Department of Psychiatry, CHA Bundang Medical Center, CHA University, 59 Yatap-ro, Bundang-gu, Seongnam-si 463-712, Gyeonggi-do, Republic of Korea
2Department of Psychiatry, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng Li Road, Tainan 70428, Taiwan
3Department of Psychiatry, Chonbuk National University Medical School, 567 Baekje-daero, Deokjin-gu, Jeonju-si 561-756, Jeollabuk-do, Republic of Korea
4Research Institute of Clinical Medicine of Chonbuk National University, Biomedical Research Institute of Chonbuk National University Hospital, 20 Geonjiro, Deokjin-gu, Jeonju-si 561-712, Jeollabuk-do, Republic of Korea

Received 13 May 2012; Accepted 22 May 2012

Academic Editor: Eduard Parellada

Copyright © 2012 Borah Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Borah Kim, Sang-Hyuk Lee, Yen Kuang Yang, Jong-Il Park, and Young-Chul Chung, “Long-Acting Injectable Antipsychotics for First-Episode Schizophrenia: The Pros and Cons,” Schizophrenia Research and Treatment, vol. 2012, Article ID 560836, 8 pages, 2012. doi:10.1155/2012/560836